# XENON PHARMACEUTICALS INC. (XENE) FY2026 Q2 P&L / Income Statement

- Company: XENON PHARMACEUTICALS INC. (XENE)
- Period: 2026-04-01 to 2026-06-30
- Filing: Q2 FY2026 10-Q, filed 2026-08-06, accession number 0001193125-26-338244
- Page: https://plicit.ai/financials/xene/fy2026-q2-income-statement
- Chart image: https://plicit.ai/charts/xene-fy2026-q2-income-statement-sankey.png

## Chart details

Income statement for 2026-04-01 through 2026-06-30. Consolidated revenue, costs and expenses.

- **Collaboration revenue (note 9)**: 0 US dollars
- **Total operating expenses**: 123,155,000 US dollars
- **Loss from operations**: negative 123,155,000 US dollars
- **Total other income**: 11,834,000 US dollars
- **Loss before income taxes**: negative 111,321,000 US dollars
- **Income tax recovery**: negative 585,000 US dollars
- **Net loss**: negative 110,736,000 US dollars
- **Total operating expenses**: 123,155,000 US dollars

### Chart connections

- Revenue minus operating expenses equals operating income.
- Operating income plus other income or expense equals income before tax. Income before tax less income tax expense or benefit equals net income.